| Literature DB >> 35045762 |
Zainab Fatima1, Blair R A Reece1, J Suzanne Moore1, Robert T Means1.
Abstract
Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.Entities:
Keywords: COVID; COVID vaccine; autoimmune hemolytic anemia; hematology oncology; hemolysis; rheumatology
Mesh:
Substances:
Year: 2022 PMID: 35045762 PMCID: PMC8777324 DOI: 10.1177/23247096211073258
Source DB: PubMed Journal: J Investig Med High Impact Case Rep ISSN: 2324-7096